All | Death | Survival | Transplant | HR (95% CI) | p-values | |
---|---|---|---|---|---|---|
Subjects (n) | 39 | 20 (51.3) | 3 (7.7) | 16 (41.0) | ||
Dornase alfa (yes) | 39 (100.0) | 20 (100.0) | 3 (100.0) | 16 (100.0) | – | – |
Colistin inhalation (yes) | 38 (97.4) | 20 (100.0) | 2 (66.7) | 16 (100.0) | 0.05 (0.0–472.26) | 0.511 |
Tobramycin inhalation (yes) | 19 (48.7) | 15 (75.0) | 1 (33.3) | 3 (18.8) | 3.82 (1.38–10.60) | 0.010 |
Azithromycin (yes) | 33 (84.6) | 16 (80.0) | 3 (100.0) | 14 (87.5) | 1.32 (0.44–4.01) | 0.622 |
Oxygen therapy (yes) | 19 (48.7) | 10 (50.0) | 3 (100.0) | 6 (37.5) | 0.55 (0.22–1.36) | 0.191 |
Pulmonary Exacerbations in the last year, median IR) | 3 (1) | 3 (1) | 2(0) | 3 (3) | 0.86 (0.61–1.21 | 0.392 |
Hospital admission in the last year (n), median (IR) | 2.1 (2.0) | 2.0 (2.0) | 0 (0.0) | 2.0 (1.0) | 1.21 (0.91–1.61) | 0.198 |
NIMV in the last year (yes) | 6 (15.4) | 2 (10.0) | 1 (33.3) | 3 (18.8) | 0.73 (0.17–3.23) | 0.692 |
ICU admission in the last year (yes) | 7 (17.9) | 2 (10.0) | 1 (33.3) | 4 (25.0) | 0.75 (0.17–3.43) | 0.713 |
Mechanical ventilation (yes) | 5 (12.8) | 2 (10.0) | 1 (33.3) | 2 (12.5) | 2.33 (0.51–10.8) | 0.278 |